Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viatris Inc.

8.99
+0.07000.78%
Post-market: 8.990.00000.00%16:05 EDT
Volume:11.17M
Turnover:100.41M
Market Cap:10.55B
PE:-2.83
High:9.07
Open:8.99
Low:8.92
Close:8.92
Loading ...

Viatris' HIV-1 Generic Medicine Gets Backing From European Medicines Agency

MT Newswires Live
·
23 May

Viatris Inc. Set to Participate in Jefferies Global Healthcare Conference

Reuters
·
22 May

Piper Sandler Adjusts Price Target on Viatris to $9 From $10, Maintains Neutral Rating

MT Newswires Live
·
22 May

Viatris Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
21 May

VTRS Lawsuit Alert! Class Action Lawsuit Against Viatris Inc.

TIPRANKS
·
16 May

Scott Andrew Smith, CEO, Reports Acquisition of Common Shares in Viatris Inc

Reuters
·
15 May

Viatris Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
15 May

Viatris Inc. Stock Slides 4.2%, Underperforms Market

Dow Jones
·
15 May

Viatris Inc. Files Initial Statement of Beneficial Ownership for Director Frank A. Damelio

Reuters
·
14 May

Viatris Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
13 May

Viatris Inc. Stock Falls 3.5%, Underperforms Market

Dow Jones
·
10 May

Viatris Inc (VTRS) Q1 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on Growth Opportunities

GuruFocus
·
09 May

BRIEF-Viatris Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
09 May

Viatris Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
09 May

Theravance Biopharma Reports 6% Increase in YUPELRI Sales, $13.6 Million Net Loss in Q1 2025

Reuters
·
09 May

Viatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock Soars

Benzinga
·
09 May

BUZZ-U.S. STOCKS ON THE MOVE-Tapestry, Carvana, PPG Industries

Reuters
·
08 May

BUZZ-Viatris rises after quarterly results beat

Reuters
·
08 May

Stock Track | Viatris Soars 5.23% on Positive Drug Trial Results and Strong Q1 Earnings

Stock Track
·
08 May

Viatris Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May